Press releases

A spotlight on the next chapter in ophthalmology

By Tom J. van Haarlem, Chief Executive Officer of VISUfarma This year’s American Academy of Ophthalmology (AAO) conference was packed with breakthroughs and early signs of what’s in store for the industry’s future. As a new name in the U.S.…
Read more

The ophthalmology gap – why should you care?

By Tom J. van Haarlem, Chief Executive Officer of VISUfarma Eye care in Europe is fragmented; knowledge and best practices are not being leveraged to the max. Large companies cast their sales nets wide, but fall short in offering both…
Read more

GHO Capital to create pan-European ophthalmic specialty pharmaceutical company

London, UK – GHO Capital, the European specialist investor in healthcare, has entered into an agreement to acquire the European commercial operations of Nicox S.A. (“Nicox”) (Euronext Paris: FR0013018124, COX), the international ophthalmic company, and to acquire the entire issued…
Read more

Meet us

OIS 2016: October 13, Chicago

The VISUfarma team will be the Ophthalmology Innovation Summit (OIS) annual meeting in Chicago on 13 October.  Click here for more information about the conference.

AAO 2016: 15-18 October, Chicago

The VISUfarma team will be the American Academy of Ophthalmology (AAO) annual meeting in Chicago from 15-18 October.  Click here for more information about the conference.

Anfrageformular

Gibt es etwas, dem wir Ihnen helfen können? Von der Anforderung eines Produktmusters, von einem unserer hilfsbereiten Kundenrepräsentanten aus, oder fragen Sie uns einfach eine Frage zu VISUfarma Produkten. Benutze das Formular und wir werden uns so schnell wie möglich in Verbindung setzen.

Die mit * gekennzeichneten Felder sind Pflichtfelder

Thank you for your enquiry!

Email Alerts

Fields indicated with * are required

Globale Internetseite

Mit dem Anklicken von "Go" stimmen Sie zu, diese regionale VISUfarma-Website zu verlassen und auf die globale VISUfarma-Website weitergeleitet zu werden

Go